Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03262415 · ClinicalTrials.gov registry record
PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor
A clinical trial, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- 30
- Enrollment target
NCT03262415 is a clinical trial that has completed, run by Joslin Diabetes Center. The registered enrollment target is 30 participants.
The verdict
NCT03262415 has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the accuracy and efficacy of the Cambridge Medical Technologies, LLC LabPatch Continuous Glucose Monitoring (CGM) System compared to a laboratory glucose analyzer (YSI 2300 STAT Plus) and 2 commercial glucometers, OneTouch Verio and Freestyle Lite. The LabPatch system includes: 1. The LabPatch circuit chip which lies in the center of a circular push-button. The circuit is in the form of a small chip (approximately 15.7 mm \[0.618"\] x 15.7 mm \[0.618"\]) placed in contact with the skin. The chip has a telescopic micropipette which draws interstitial fluid to be analyzed for glucose levels. The chip is also able to measure skin temperature to ensure appropriate skin contact. 2. A Lab Patch holding device (blue box). 3. A wire that connects the chip to a laptop that continuously captures glucose data.
Interventions
- DEVICE LabPatch Continuous Glucose Monitoring (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2019-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03262415
The ClinicalTrials.gov registry entry for NCT03262415 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LabPatch Continuous Glucose Monitoring (CGM) is the first listed.
NCT03262415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03262415 about?
NCT03262415 is a clinical study titled "PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor". The purpose of this study is to evaluate the accuracy and efficacy of the Cambridge Medical Technologies, LLC LabPatch Continuous Glucose Monitoring (CGM) System compared to a laboratory glucose analyzer (YSI 2300 STAT Plus) and 2 commercial glucometers, OneTouch Verio and Freestyle Lite. The LabPa...
What is the current status of trial NCT03262415?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-02-17. Estimated completion is 2019-05-22.
What interventions are being tested in trial NCT03262415?
The interventions under investigation include: LabPatch Continuous Glucose Monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT03262415?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.